nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ESR2—urinary bladder cancer	0.41	0.619	CbGaD
Estropipate—ESR1—urinary bladder cancer	0.252	0.381	CbGaD
Estropipate—ALB—Fluorouracil—urinary bladder cancer	0.025	0.198	CbGbCtD
Estropipate—CYP3A4—Thiotepa—urinary bladder cancer	0.0241	0.191	CbGbCtD
Estropipate—CYP1A2—Fluorouracil—urinary bladder cancer	0.0149	0.118	CbGbCtD
Estropipate—ALB—Methotrexate—urinary bladder cancer	0.0138	0.109	CbGbCtD
Estropipate—CYP2C9—Fluorouracil—urinary bladder cancer	0.0135	0.107	CbGbCtD
Estropipate—CYP1A2—Etoposide—urinary bladder cancer	0.0125	0.0989	CbGbCtD
Estropipate—CYP2C9—Cisplatin—urinary bladder cancer	0.0114	0.0907	CbGbCtD
Estropipate—CYP3A4—Etoposide—urinary bladder cancer	0.00653	0.0518	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—urinary bladder cancer	0.00446	0.0353	CbGbCtD
Estropipate—CYP1A2—urine—urinary bladder cancer	0.00235	0.093	CbGeAlD
Estropipate—CYP2C9—urine—urinary bladder cancer	0.00223	0.0883	CbGeAlD
Estropipate—CYP3A4—urine—urinary bladder cancer	0.0017	0.0673	CbGeAlD
Estropipate—ESR2—prostate gland—urinary bladder cancer	0.0016	0.0632	CbGeAlD
Estropipate—SHBG—prostate gland—urinary bladder cancer	0.00155	0.0615	CbGeAlD
Estropipate—ESR2—epithelium—urinary bladder cancer	0.00117	0.0465	CbGeAlD
Estropipate—ESR2—smooth muscle tissue—urinary bladder cancer	0.00113	0.0448	CbGeAlD
Estropipate—ESR1—prostate gland—urinary bladder cancer	0.00109	0.0433	CbGeAlD
Estropipate—ESR2—renal system—urinary bladder cancer	0.00109	0.0431	CbGeAlD
Estropipate—SLC22A1—renal system—urinary bladder cancer	0.000912	0.0361	CbGeAlD
Estropipate—ESR2—female reproductive system—urinary bladder cancer	0.000871	0.0345	CbGeAlD
Estropipate—SHBG—female reproductive system—urinary bladder cancer	0.000846	0.0336	CbGeAlD
Estropipate—ESR1—epithelium—urinary bladder cancer	0.000803	0.0318	CbGeAlD
Estropipate—ESR2—vagina—urinary bladder cancer	0.000788	0.0312	CbGeAlD
Estropipate—ESR1—smooth muscle tissue—urinary bladder cancer	0.000774	0.0307	CbGeAlD
Estropipate—SHBG—vagina—urinary bladder cancer	0.000766	0.0304	CbGeAlD
Estropipate—Estriol—ESR2—urinary bladder cancer	0.000749	0.129	CrCbGaD
Estropipate—ESR1—renal system—urinary bladder cancer	0.000745	0.0295	CbGeAlD
Estropipate—Quinestrol—ESR1—urinary bladder cancer	0.000697	0.12	CrCbGaD
Estropipate—Estramustine—ESR2—urinary bladder cancer	0.000696	0.12	CrCbGaD
Estropipate—SLC22A1—vagina—urinary bladder cancer	0.00066	0.0262	CbGeAlD
Estropipate—ESR1—female reproductive system—urinary bladder cancer	0.000596	0.0236	CbGeAlD
Estropipate—CYP1A2—renal system—urinary bladder cancer	0.000574	0.0228	CbGeAlD
Estropipate—ESR1—vagina—urinary bladder cancer	0.000539	0.0214	CbGeAlD
Estropipate—Mestranol—ESR1—urinary bladder cancer	0.000529	0.091	CrCbGaD
Estropipate—ESR2—lymph node—urinary bladder cancer	0.000509	0.0202	CbGeAlD
Estropipate—Estriol—ESR1—urinary bladder cancer	0.000461	0.0794	CrCbGaD
Estropipate—CYP2C9—female reproductive system—urinary bladder cancer	0.000436	0.0173	CbGeAlD
Estropipate—Estramustine—ESR1—urinary bladder cancer	0.000429	0.0738	CrCbGaD
Estropipate—CYP3A4—renal system—urinary bladder cancer	0.000415	0.0165	CbGeAlD
Estropipate—ALB—lymph node—urinary bladder cancer	0.000409	0.0162	CbGeAlD
Estropipate—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000409	0.0704	CrCbGaD
Estropipate—Conjugated Estrogens—ESR2—urinary bladder cancer	0.000357	0.0615	CrCbGaD
Estropipate—Estrone—ESR2—urinary bladder cancer	0.000356	0.0613	CrCbGaD
Estropipate—ESR1—lymph node—urinary bladder cancer	0.000349	0.0138	CbGeAlD
Estropipate—CYP3A4—female reproductive system—urinary bladder cancer	0.000333	0.0132	CbGeAlD
Estropipate—Estradiol—ESR2—urinary bladder cancer	0.00027	0.0465	CrCbGaD
Estropipate—Ethinyl Estradiol—ESR1—urinary bladder cancer	0.000252	0.0434	CrCbGaD
Estropipate—Conjugated Estrogens—ESR1—urinary bladder cancer	0.00022	0.0379	CrCbGaD
Estropipate—Estrone—ESR1—urinary bladder cancer	0.000219	0.0378	CrCbGaD
Estropipate—Estradiol—ESR1—urinary bladder cancer	0.000166	0.0286	CrCbGaD
Estropipate—Asthenia—Thiotepa—urinary bladder cancer	0.000128	0.00103	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000127	0.00102	CcSEcCtD
Estropipate—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000127	0.00102	CcSEcCtD
Estropipate—Infection—Etoposide—urinary bladder cancer	0.000127	0.00102	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—urinary bladder cancer	0.000127	0.00102	CcSEcCtD
Estropipate—Asthma—Epirubicin—urinary bladder cancer	0.000126	0.00101	CcSEcCtD
Estropipate—Influenza—Epirubicin—urinary bladder cancer	0.000126	0.00101	CcSEcCtD
Estropipate—Dysuria—Methotrexate—urinary bladder cancer	0.000126	0.00101	CcSEcCtD
Estropipate—Pruritus—Thiotepa—urinary bladder cancer	0.000126	0.00101	CcSEcCtD
Estropipate—Pain—Fluorouracil—urinary bladder cancer	0.000126	0.00101	CcSEcCtD
Estropipate—Paraesthesia—Cisplatin—urinary bladder cancer	0.000125	0.00101	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000125	0.00101	CcSEcCtD
Estropipate—Skin disorder—Etoposide—urinary bladder cancer	0.000124	0.000997	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—urinary bladder cancer	0.000124	0.000992	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—urinary bladder cancer	0.000122	0.000979	CcSEcCtD
Estropipate—Diarrhoea—Thiotepa—urinary bladder cancer	0.000122	0.000978	CcSEcCtD
Estropipate—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000121	0.000968	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—urinary bladder cancer	0.00012	0.000964	CcSEcCtD
Estropipate—Infestation—Methotrexate—urinary bladder cancer	0.00012	0.000964	CcSEcCtD
Estropipate—Depression—Methotrexate—urinary bladder cancer	0.00012	0.000961	CcSEcCtD
Estropipate—Pain—Cisplatin—urinary bladder cancer	0.000119	0.000958	CcSEcCtD
Estropipate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000118	0.000951	CcSEcCtD
Estropipate—Dysuria—Epirubicin—urinary bladder cancer	0.000118	0.000946	CcSEcCtD
Estropipate—Dizziness—Thiotepa—urinary bladder cancer	0.000118	0.000945	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000117	0.000943	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000117	0.000941	CcSEcCtD
Estropipate—Urticaria—Fluorouracil—urinary bladder cancer	0.000117	0.000939	CcSEcCtD
Estropipate—Asthma—Doxorubicin—urinary bladder cancer	0.000117	0.000936	CcSEcCtD
Estropipate—Influenza—Doxorubicin—urinary bladder cancer	0.000117	0.000936	CcSEcCtD
Estropipate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000116	0.000935	CcSEcCtD
Estropipate—Paraesthesia—Etoposide—urinary bladder cancer	0.000115	0.000922	CcSEcCtD
Estropipate—Weight increased—Epirubicin—urinary bladder cancer	0.000115	0.000921	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000114	0.000918	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000114	0.000913	CcSEcCtD
Estropipate—Somnolence—Etoposide—urinary bladder cancer	0.000114	0.000913	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000114	0.000912	CcSEcCtD
Estropipate—Vomiting—Thiotepa—urinary bladder cancer	0.000113	0.000909	CcSEcCtD
Estropipate—Infestation—Epirubicin—urinary bladder cancer	0.000112	0.000902	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—urinary bladder cancer	0.000112	0.000902	CcSEcCtD
Estropipate—Rash—Thiotepa—urinary bladder cancer	0.000112	0.000901	CcSEcCtD
Estropipate—Dermatitis—Thiotepa—urinary bladder cancer	0.000112	0.0009	CcSEcCtD
Estropipate—Headache—Thiotepa—urinary bladder cancer	0.000112	0.000895	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00011	0.000886	CcSEcCtD
Estropipate—Body temperature increased—Cisplatin—urinary bladder cancer	0.00011	0.000886	CcSEcCtD
Estropipate—Fatigue—Etoposide—urinary bladder cancer	0.00011	0.000885	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00011	0.000885	CcSEcCtD
Estropipate—Pain—Etoposide—urinary bladder cancer	0.000109	0.000878	CcSEcCtD
Estropipate—Constipation—Etoposide—urinary bladder cancer	0.000109	0.000878	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—urinary bladder cancer	0.000109	0.000876	CcSEcCtD
Estropipate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000109	0.000871	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000108	0.00087	CcSEcCtD
Estropipate—Asthenia—Gemcitabine—urinary bladder cancer	0.000107	0.000863	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—urinary bladder cancer	0.000107	0.000859	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000106	0.000853	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—urinary bladder cancer	0.000106	0.000852	CcSEcCtD
Estropipate—Pruritus—Gemcitabine—urinary bladder cancer	0.000106	0.000851	CcSEcCtD
Estropipate—Nausea—Thiotepa—urinary bladder cancer	0.000106	0.000849	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—urinary bladder cancer	0.000105	0.000847	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000105	0.000845	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000105	0.00084	CcSEcCtD
Estropipate—Pruritus—Fluorouracil—urinary bladder cancer	0.000104	0.000836	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000104	0.000835	CcSEcCtD
Estropipate—Infestation—Doxorubicin—urinary bladder cancer	0.000104	0.000835	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—urinary bladder cancer	0.000104	0.000834	CcSEcCtD
Estropipate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000103	0.000826	CcSEcCtD
Estropipate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000103	0.000823	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000102	0.000818	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000102	0.000818	CcSEcCtD
Estropipate—Urticaria—Etoposide—urinary bladder cancer	0.000102	0.000816	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—urinary bladder cancer	0.000101	0.000812	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—urinary bladder cancer	0.000101	0.000812	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—urinary bladder cancer	0.000101	0.000812	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—urinary bladder cancer	0.000101	0.000809	CcSEcCtD
Estropipate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000101	0.000809	CcSEcCtD
Estropipate—Asthenia—Cisplatin—urinary bladder cancer	0.0001	0.000804	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—urinary bladder cancer	0.0001	0.000804	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—urinary bladder cancer	0.0001	0.000803	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—urinary bladder cancer	9.94e-05	0.000798	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	9.84e-05	0.00079	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—urinary bladder cancer	9.79e-05	0.000785	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—urinary bladder cancer	9.76e-05	0.000783	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—urinary bladder cancer	9.74e-05	0.000782	CcSEcCtD
Estropipate—Dizziness—Fluorouracil—urinary bladder cancer	9.74e-05	0.000782	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—urinary bladder cancer	9.73e-05	0.000781	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—urinary bladder cancer	9.72e-05	0.00078	CcSEcCtD
Estropipate—Diarrhoea—Cisplatin—urinary bladder cancer	9.55e-05	0.000767	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—urinary bladder cancer	9.54e-05	0.000766	CcSEcCtD
Estropipate—Alopecia—Methotrexate—urinary bladder cancer	9.53e-05	0.000765	CcSEcCtD
Estropipate—Vomiting—Gemcitabine—urinary bladder cancer	9.53e-05	0.000765	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—urinary bladder cancer	9.45e-05	0.000758	CcSEcCtD
Estropipate—Rash—Gemcitabine—urinary bladder cancer	9.45e-05	0.000758	CcSEcCtD
Estropipate—Dermatitis—Gemcitabine—urinary bladder cancer	9.44e-05	0.000757	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—urinary bladder cancer	9.43e-05	0.000757	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—urinary bladder cancer	9.43e-05	0.000756	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—urinary bladder cancer	9.39e-05	0.000754	CcSEcCtD
Estropipate—Erythema—Methotrexate—urinary bladder cancer	9.39e-05	0.000754	CcSEcCtD
Estropipate—Headache—Gemcitabine—urinary bladder cancer	9.39e-05	0.000753	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—urinary bladder cancer	9.37e-05	0.000752	CcSEcCtD
Estropipate—Vomiting—Fluorouracil—urinary bladder cancer	9.37e-05	0.000752	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—urinary bladder cancer	9.36e-05	0.000751	CcSEcCtD
Estropipate—Rash—Fluorouracil—urinary bladder cancer	9.29e-05	0.000745	CcSEcCtD
Estropipate—Dermatitis—Fluorouracil—urinary bladder cancer	9.28e-05	0.000745	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—urinary bladder cancer	9.27e-05	0.000744	CcSEcCtD
Estropipate—Headache—Fluorouracil—urinary bladder cancer	9.23e-05	0.000741	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—urinary bladder cancer	9.2e-05	0.000738	CcSEcCtD
Estropipate—Asthenia—Etoposide—urinary bladder cancer	9.18e-05	0.000737	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—urinary bladder cancer	9.16e-05	0.000735	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—urinary bladder cancer	9.12e-05	0.000732	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—urinary bladder cancer	9.1e-05	0.00073	CcSEcCtD
Estropipate—Back pain—Methotrexate—urinary bladder cancer	9.08e-05	0.000729	CcSEcCtD
Estropipate—Pruritus—Etoposide—urinary bladder cancer	9.05e-05	0.000726	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—urinary bladder cancer	9e-05	0.000722	CcSEcCtD
Estropipate—Alopecia—Epirubicin—urinary bladder cancer	8.92e-05	0.000716	CcSEcCtD
Estropipate—Nausea—Gemcitabine—urinary bladder cancer	8.9e-05	0.000714	CcSEcCtD
Estropipate—Vomiting—Cisplatin—urinary bladder cancer	8.88e-05	0.000713	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—urinary bladder cancer	8.84e-05	0.00071	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—urinary bladder cancer	8.83e-05	0.000709	CcSEcCtD
Estropipate—Rash—Cisplatin—urinary bladder cancer	8.8e-05	0.000707	CcSEcCtD
Estropipate—Dermatitis—Cisplatin—urinary bladder cancer	8.8e-05	0.000706	CcSEcCtD
Estropipate—Erythema—Epirubicin—urinary bladder cancer	8.79e-05	0.000705	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—urinary bladder cancer	8.79e-05	0.000705	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—urinary bladder cancer	8.75e-05	0.000703	CcSEcCtD
Estropipate—Nausea—Fluorouracil—urinary bladder cancer	8.75e-05	0.000702	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—urinary bladder cancer	8.73e-05	0.0007	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—urinary bladder cancer	8.67e-05	0.000696	CcSEcCtD
Estropipate—Flatulence—Epirubicin—urinary bladder cancer	8.66e-05	0.000695	CcSEcCtD
Estropipate—Tension—Epirubicin—urinary bladder cancer	8.62e-05	0.000692	CcSEcCtD
Estropipate—Nervousness—Epirubicin—urinary bladder cancer	8.53e-05	0.000685	CcSEcCtD
Estropipate—Back pain—Epirubicin—urinary bladder cancer	8.5e-05	0.000682	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—urinary bladder cancer	8.47e-05	0.00068	CcSEcCtD
Estropipate—Dizziness—Etoposide—urinary bladder cancer	8.46e-05	0.000679	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—urinary bladder cancer	8.45e-05	0.000678	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—urinary bladder cancer	8.44e-05	0.000677	CcSEcCtD
Estropipate—Vertigo—Methotrexate—urinary bladder cancer	8.44e-05	0.000677	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	8.42e-05	0.000676	CcSEcCtD
Estropipate—Nausea—Cisplatin—urinary bladder cancer	8.29e-05	0.000666	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—urinary bladder cancer	8.25e-05	0.000662	CcSEcCtD
Estropipate—Cough—Methotrexate—urinary bladder cancer	8.19e-05	0.000658	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—urinary bladder cancer	8.18e-05	0.000657	CcSEcCtD
Estropipate—Vomiting—Etoposide—urinary bladder cancer	8.13e-05	0.000653	CcSEcCtD
Estropipate—Erythema—Doxorubicin—urinary bladder cancer	8.13e-05	0.000653	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—urinary bladder cancer	8.13e-05	0.000653	CcSEcCtD
Estropipate—Rash—Etoposide—urinary bladder cancer	8.07e-05	0.000647	CcSEcCtD
Estropipate—Dermatitis—Etoposide—urinary bladder cancer	8.06e-05	0.000647	CcSEcCtD
Estropipate—Headache—Etoposide—urinary bladder cancer	8.01e-05	0.000643	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—urinary bladder cancer	8.01e-05	0.000643	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—urinary bladder cancer	7.99e-05	0.000642	CcSEcCtD
Estropipate—Myalgia—Methotrexate—urinary bladder cancer	7.99e-05	0.000642	CcSEcCtD
Estropipate—Tension—Doxorubicin—urinary bladder cancer	7.98e-05	0.00064	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	7.94e-05	0.000637	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—urinary bladder cancer	7.9e-05	0.000634	CcSEcCtD
Estropipate—Vertigo—Epirubicin—urinary bladder cancer	7.89e-05	0.000634	CcSEcCtD
Estropipate—Back pain—Doxorubicin—urinary bladder cancer	7.86e-05	0.000631	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—urinary bladder cancer	7.82e-05	0.000627	CcSEcCtD
Estropipate—Palpitations—Epirubicin—urinary bladder cancer	7.76e-05	0.000623	CcSEcCtD
Estropipate—Cough—Epirubicin—urinary bladder cancer	7.67e-05	0.000615	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—urinary bladder cancer	7.66e-05	0.000615	CcSEcCtD
Estropipate—Infection—Methotrexate—urinary bladder cancer	7.61e-05	0.000611	CcSEcCtD
Estropipate—Nausea—Etoposide—urinary bladder cancer	7.6e-05	0.00061	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—urinary bladder cancer	7.51e-05	0.000603	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—urinary bladder cancer	7.48e-05	0.0006	CcSEcCtD
Estropipate—Myalgia—Epirubicin—urinary bladder cancer	7.48e-05	0.0006	CcSEcCtD
Estropipate—Anxiety—Epirubicin—urinary bladder cancer	7.45e-05	0.000598	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—urinary bladder cancer	7.44e-05	0.000597	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	7.43e-05	0.000596	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—urinary bladder cancer	7.3e-05	0.000586	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—urinary bladder cancer	7.18e-05	0.000577	CcSEcCtD
Estropipate—Oedema—Epirubicin—urinary bladder cancer	7.17e-05	0.000576	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—urinary bladder cancer	7.17e-05	0.000576	CcSEcCtD
Estropipate—Infection—Epirubicin—urinary bladder cancer	7.12e-05	0.000572	CcSEcCtD
Estropipate—Cough—Doxorubicin—urinary bladder cancer	7.09e-05	0.000569	CcSEcCtD
Estropipate—Nervous system disorder—Epirubicin—urinary bladder cancer	7.03e-05	0.000564	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	6.98e-05	0.00056	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—urinary bladder cancer	6.97e-05	0.000559	CcSEcCtD
Estropipate—Insomnia—Methotrexate—urinary bladder cancer	6.93e-05	0.000556	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—urinary bladder cancer	6.92e-05	0.000556	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—urinary bladder cancer	6.92e-05	0.000556	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—urinary bladder cancer	6.9e-05	0.000554	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—urinary bladder cancer	6.88e-05	0.000552	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	6.87e-05	0.000552	CcSEcCtD
Estropipate—Somnolence—Methotrexate—urinary bladder cancer	6.81e-05	0.000547	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—urinary bladder cancer	6.75e-05	0.000541	CcSEcCtD
Estropipate—Oedema—Doxorubicin—urinary bladder cancer	6.64e-05	0.000533	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	6.64e-05	0.000533	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	6.62e-05	0.000531	CcSEcCtD
Estropipate—Fatigue—Methotrexate—urinary bladder cancer	6.61e-05	0.00053	CcSEcCtD
Estropipate—Infection—Doxorubicin—urinary bladder cancer	6.59e-05	0.000529	CcSEcCtD
Estropipate—Pain—Methotrexate—urinary bladder cancer	6.55e-05	0.000526	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	6.53e-05	0.000524	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—urinary bladder cancer	6.51e-05	0.000522	CcSEcCtD
Estropipate—Insomnia—Epirubicin—urinary bladder cancer	6.49e-05	0.000521	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—urinary bladder cancer	6.45e-05	0.000517	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—urinary bladder cancer	6.44e-05	0.000517	CcSEcCtD
Estropipate—Somnolence—Epirubicin—urinary bladder cancer	6.38e-05	0.000512	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—urinary bladder cancer	6.31e-05	0.000507	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	6.27e-05	0.000503	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	6.19e-05	0.000497	CcSEcCtD
Estropipate—Fatigue—Epirubicin—urinary bladder cancer	6.18e-05	0.000496	CcSEcCtD
Estropipate—Pain—Epirubicin—urinary bladder cancer	6.13e-05	0.000492	CcSEcCtD
Estropipate—Constipation—Epirubicin—urinary bladder cancer	6.13e-05	0.000492	CcSEcCtD
Estropipate—Urticaria—Methotrexate—urinary bladder cancer	6.09e-05	0.000489	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—urinary bladder cancer	6.06e-05	0.000486	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—urinary bladder cancer	6.06e-05	0.000486	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	6.05e-05	0.000485	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—urinary bladder cancer	6e-05	0.000482	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—urinary bladder cancer	5.96e-05	0.000478	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—urinary bladder cancer	5.9e-05	0.000473	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	5.86e-05	0.000471	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—urinary bladder cancer	5.84e-05	0.000469	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	5.73e-05	0.00046	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—urinary bladder cancer	5.72e-05	0.000459	CcSEcCtD
Estropipate—Urticaria—Epirubicin—urinary bladder cancer	5.7e-05	0.000457	CcSEcCtD
Estropipate—Pain—Doxorubicin—urinary bladder cancer	5.67e-05	0.000455	CcSEcCtD
Estropipate—Constipation—Doxorubicin—urinary bladder cancer	5.67e-05	0.000455	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—urinary bladder cancer	5.67e-05	0.000455	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—urinary bladder cancer	5.67e-05	0.000455	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—urinary bladder cancer	5.65e-05	0.000453	CcSEcCtD
Estropipate—Asthenia—Methotrexate—urinary bladder cancer	5.5e-05	0.000441	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	5.43e-05	0.000435	CcSEcCtD
Estropipate—Pruritus—Methotrexate—urinary bladder cancer	5.42e-05	0.000435	CcSEcCtD
Estropipate—Hypersensitivity—Epirubicin—urinary bladder cancer	5.28e-05	0.000424	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—urinary bladder cancer	5.27e-05	0.000423	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—urinary bladder cancer	5.25e-05	0.000421	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—urinary bladder cancer	5.25e-05	0.000421	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—urinary bladder cancer	5.24e-05	0.000421	CcSEcCtD
Estropipate—Asthenia—Epirubicin—urinary bladder cancer	5.15e-05	0.000413	CcSEcCtD
Estropipate—Pruritus—Epirubicin—urinary bladder cancer	5.07e-05	0.000407	CcSEcCtD
Estropipate—Dizziness—Methotrexate—urinary bladder cancer	5.07e-05	0.000407	CcSEcCtD
Estropipate—Diarrhoea—Epirubicin—urinary bladder cancer	4.91e-05	0.000394	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.89e-05	0.000392	CcSEcCtD
Estropipate—Vomiting—Methotrexate—urinary bladder cancer	4.87e-05	0.000391	CcSEcCtD
Estropipate—Rash—Methotrexate—urinary bladder cancer	4.83e-05	0.000388	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—urinary bladder cancer	4.83e-05	0.000387	CcSEcCtD
Estropipate—Headache—Methotrexate—urinary bladder cancer	4.8e-05	0.000385	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—urinary bladder cancer	4.76e-05	0.000382	CcSEcCtD
Estropipate—Dizziness—Epirubicin—urinary bladder cancer	4.74e-05	0.000381	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—urinary bladder cancer	4.69e-05	0.000377	CcSEcCtD
Estropipate—Vomiting—Epirubicin—urinary bladder cancer	4.56e-05	0.000366	CcSEcCtD
Estropipate—Nausea—Methotrexate—urinary bladder cancer	4.55e-05	0.000365	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—urinary bladder cancer	4.54e-05	0.000364	CcSEcCtD
Estropipate—Rash—Epirubicin—urinary bladder cancer	4.52e-05	0.000363	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—urinary bladder cancer	4.52e-05	0.000363	CcSEcCtD
Estropipate—Headache—Epirubicin—urinary bladder cancer	4.49e-05	0.000361	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—urinary bladder cancer	4.39e-05	0.000352	CcSEcCtD
Estropipate—Nausea—Epirubicin—urinary bladder cancer	4.26e-05	0.000342	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—urinary bladder cancer	4.22e-05	0.000339	CcSEcCtD
Estropipate—Rash—Doxorubicin—urinary bladder cancer	4.18e-05	0.000336	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—urinary bladder cancer	4.18e-05	0.000335	CcSEcCtD
Estropipate—Headache—Doxorubicin—urinary bladder cancer	4.16e-05	0.000334	CcSEcCtD
Estropipate—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.99e-05	0.000707	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.97e-05	0.000703	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	3.97e-05	0.000703	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	3.97e-05	0.000703	CbGpPWpGaD
Estropipate—Nausea—Doxorubicin—urinary bladder cancer	3.94e-05	0.000316	CcSEcCtD
Estropipate—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.93e-05	0.000697	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP4B1—urinary bladder cancer	3.84e-05	0.000681	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.83e-05	0.00068	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	3.78e-05	0.00067	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	3.78e-05	0.00067	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	3.76e-05	0.000667	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	3.75e-05	0.000664	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	3.74e-05	0.000663	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	3.71e-05	0.000658	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.71e-05	0.000658	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.71e-05	0.000657	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.7e-05	0.000656	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC19A1—urinary bladder cancer	3.63e-05	0.000644	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	3.63e-05	0.000643	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	3.61e-05	0.00064	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—NCOR1—urinary bladder cancer	3.57e-05	0.000633	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—urinary bladder cancer	3.57e-05	0.000632	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PRSS3—urinary bladder cancer	3.54e-05	0.000627	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.53e-05	0.000626	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	3.45e-05	0.000613	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.43e-05	0.000608	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	3.43e-05	0.000608	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	3.41e-05	0.000605	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.41e-05	0.000604	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ERCC2—urinary bladder cancer	3.35e-05	0.000595	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTZ1—urinary bladder cancer	3.29e-05	0.000584	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	3.21e-05	0.00057	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	3.18e-05	0.000565	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	3.13e-05	0.000554	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTO2—urinary bladder cancer	3.12e-05	0.000554	CbGpPWpGaD
Estropipate—ALB—Metabolism—NAT1—urinary bladder cancer	3.12e-05	0.000554	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.07e-05	0.000545	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.07e-05	0.000544	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	3.05e-05	0.00054	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—MYC—urinary bladder cancer	3.03e-05	0.000537	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.01e-05	0.000533	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.9e-05	0.000515	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	2.9e-05	0.000514	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.86e-05	0.000508	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.86e-05	0.000508	CbGpPWpGaD
Estropipate—ALB—Metabolism—UGT2B7—urinary bladder cancer	2.85e-05	0.000506	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.84e-05	0.000504	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TYMP—urinary bladder cancer	2.83e-05	0.000501	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ESR1—urinary bladder cancer	2.8e-05	0.000497	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	2.75e-05	0.000487	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	2.7e-05	0.000478	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	2.68e-05	0.000475	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SMC1A—urinary bladder cancer	2.67e-05	0.000474	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.67e-05	0.000473	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.65e-05	0.000471	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.63e-05	0.000466	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	2.62e-05	0.000464	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	2.57e-05	0.000456	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP4B1—urinary bladder cancer	2.57e-05	0.000456	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—PPARG—urinary bladder cancer	2.56e-05	0.000453	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NAT2—urinary bladder cancer	2.56e-05	0.000453	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	2.56e-05	0.000453	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NAT1—urinary bladder cancer	2.56e-05	0.000453	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.52e-05	0.000448	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.52e-05	0.000446	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.51e-05	0.000446	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—CREBBP—urinary bladder cancer	2.46e-05	0.000436	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IFNA2—urinary bladder cancer	2.45e-05	0.000435	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC19A1—urinary bladder cancer	2.43e-05	0.000431	CbGpPWpGaD
Estropipate—ALB—Metabolism—PRSS3—urinary bladder cancer	2.37e-05	0.00042	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	2.34e-05	0.000414	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ESR2—urinary bladder cancer	2.33e-05	0.000413	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	2.3e-05	0.000408	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—RRM2—urinary bladder cancer	2.21e-05	0.000391	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	2.18e-05	0.000387	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NAT1—urinary bladder cancer	2.18e-05	0.000387	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.15e-05	0.000381	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.11e-05	0.000375	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.1e-05	0.000373	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	2.1e-05	0.000372	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	2.04e-05	0.000362	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ENO2—urinary bladder cancer	2.04e-05	0.000362	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	2e-05	0.000354	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.99e-05	0.000352	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	1.98e-05	0.000352	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.94e-05	0.000343	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.9e-05	0.000336	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMP—urinary bladder cancer	1.89e-05	0.000335	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.86e-05	0.000329	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.84e-05	0.000327	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.82e-05	0.000322	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—NCOR1—urinary bladder cancer	1.8e-05	0.000319	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.8e-05	0.000319	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	1.79e-05	0.000318	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.78e-05	0.000315	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLAU—urinary bladder cancer	1.74e-05	0.000308	CbGpPWpGaD
Estropipate—ALB—Metabolism—NAT2—urinary bladder cancer	1.71e-05	0.000303	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.7e-05	0.000301	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ERCC2—urinary bladder cancer	1.69e-05	0.0003	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	1.69e-05	0.000299	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.69e-05	0.000299	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.69e-05	0.000299	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.65e-05	0.000293	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NQO1—urinary bladder cancer	1.65e-05	0.000292	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	1.61e-05	0.000285	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	1.61e-05	0.000285	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.55e-05	0.000275	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.55e-05	0.000275	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.54e-05	0.000273	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	1.53e-05	0.000271	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.49e-05	0.000264	CbGpPWpGaD
Estropipate—ALB—Metabolism—RRM2—urinary bladder cancer	1.48e-05	0.000262	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—urinary bladder cancer	1.46e-05	0.000259	CbGpPWpGaD
Estropipate—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.43e-05	0.000254	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IGF1—urinary bladder cancer	1.42e-05	0.000251	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.4e-05	0.000248	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.39e-05	0.000246	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	0.000244	CbGpPWpGaD
Estropipate—ALB—Metabolism—ENO2—urinary bladder cancer	1.37e-05	0.000242	CbGpPWpGaD
Estropipate—ALB—Metabolism—HPGDS—urinary bladder cancer	1.37e-05	0.000242	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.36e-05	0.000241	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.33e-05	0.000235	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTT1—urinary bladder cancer	1.33e-05	0.000235	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.32e-05	0.000235	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.31e-05	0.000232	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.31e-05	0.000232	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—S100B—urinary bladder cancer	1.3e-05	0.000231	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RHOA—urinary bladder cancer	1.3e-05	0.00023	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARG—urinary bladder cancer	1.29e-05	0.000229	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.28e-05	0.000227	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.28e-05	0.000226	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.27e-05	0.000225	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.000224	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.000224	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.24e-05	0.00022	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CREBBP—urinary bladder cancer	1.24e-05	0.00022	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.21e-05	0.000214	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.21e-05	0.000214	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.2e-05	0.000212	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.19e-05	0.000211	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	1.17e-05	0.000207	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.12e-05	0.000198	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.12e-05	0.000198	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.12e-05	0.000198	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.11e-05	0.000197	CbGpPWpGaD
Estropipate—ALB—Metabolism—NQO1—urinary bladder cancer	1.1e-05	0.000195	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—urinary bladder cancer	1.09e-05	0.000193	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.09e-05	0.000193	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.07e-05	0.00019	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.07e-05	0.00019	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.03e-05	0.000183	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—urinary bladder cancer	1.03e-05	0.000183	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.02e-05	0.000181	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EP300—urinary bladder cancer	9.77e-06	0.000173	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO2—urinary bladder cancer	9.56e-06	0.00017	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	9.56e-06	0.00017	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.51e-06	0.000169	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SRC—urinary bladder cancer	9.5e-06	0.000168	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	9.46e-06	0.000168	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.33e-06	0.000165	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	9.28e-06	0.000165	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.23e-06	0.000164	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—urinary bladder cancer	9.19e-06	0.000163	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.13e-06	0.000162	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARG—urinary bladder cancer	9.05e-06	0.00016	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NQO1—urinary bladder cancer	9.02e-06	0.00016	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.89e-06	0.000158	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.75e-06	0.000155	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	8.69e-06	0.000154	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMS—urinary bladder cancer	8.55e-06	0.000152	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—urinary bladder cancer	8.45e-06	0.00015	CbGpPWpGaD
Estropipate—ALB—Metabolism—NCOR1—urinary bladder cancer	8.45e-06	0.00015	CbGpPWpGaD
Estropipate—ALB—Metabolism—GPX1—urinary bladder cancer	8.09e-06	0.000143	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	8.05e-06	0.000143	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.97e-06	0.000141	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	7.95e-06	0.000141	CbGpPWpGaD
Estropipate—ALB—Metabolism—ERCC2—urinary bladder cancer	7.94e-06	0.000141	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—urinary bladder cancer	7.87e-06	0.000139	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NQO1—urinary bladder cancer	7.71e-06	0.000137	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.63e-06	0.000135	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	7.52e-06	0.000133	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.48e-06	0.000133	CbGpPWpGaD
Estropipate—ALB—Metabolism—MTHFR—urinary bladder cancer	7.47e-06	0.000132	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.38e-06	0.000131	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.38e-06	0.000131	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—urinary bladder cancer	7.35e-06	0.00013	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	7.29e-06	0.000129	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.28e-06	0.000129	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.16e-06	0.000127	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	7.12e-06	0.000126	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.99e-06	0.000124	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—urinary bladder cancer	6.99e-06	0.000124	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.91e-06	0.000123	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.91e-06	0.000123	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	6.74e-06	0.00012	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—urinary bladder cancer	6.69e-06	0.000119	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.62e-06	0.000117	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.52e-06	0.000116	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	6.5e-06	0.000115	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	6.43e-06	0.000114	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	6.4e-06	0.000113	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.22e-06	0.00011	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—urinary bladder cancer	6.21e-06	0.00011	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—urinary bladder cancer	6.11e-06	0.000108	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	6.11e-06	0.000108	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARG—urinary bladder cancer	6.05e-06	0.000107	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMS—urinary bladder cancer	5.98e-06	0.000106	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	5.96e-06	0.000106	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.95e-06	0.000106	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—EP300—urinary bladder cancer	5.92e-06	0.000105	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	5.91e-06	0.000105	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	5.91e-06	0.000105	CbGpPWpGaD
Estropipate—ALB—Metabolism—CREBBP—urinary bladder cancer	5.82e-06	0.000103	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	5.78e-06	0.000103	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.76e-06	0.000102	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	5.75e-06	0.000102	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.66e-06	0.0001	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.56e-06	9.85e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EP300—urinary bladder cancer	5.48e-06	9.73e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SRC—urinary bladder cancer	5.33e-06	9.46e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.22e-06	9.26e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.96e-06	8.8e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.96e-06	8.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—urinary bladder cancer	4.78e-06	8.48e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—urinary bladder cancer	4.76e-06	8.45e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.76e-06	8.44e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	4.67e-06	8.29e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.61e-06	8.18e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.56e-06	8.09e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.56e-06	8.09e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	4.42e-06	7.83e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.37e-06	7.74e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.29e-06	7.6e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.23e-06	7.51e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—urinary bladder cancer	4.15e-06	7.37e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.07e-06	7.21e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.03e-06	7.15e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—EP300—urinary bladder cancer	3.96e-06	7.02e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—urinary bladder cancer	3.92e-06	6.96e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.9e-06	6.91e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	3.75e-06	6.66e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.4e-06	6.03e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.33e-06	5.91e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.27e-06	5.8e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.24e-06	5.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.14e-06	5.57e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.9e-06	5.15e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.77e-06	4.91e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.57e-06	4.56e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.24e-06	3.98e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.14e-06	3.79e-05	CbGpPWpGaD
